Assessment of the Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

November 1, 2021

Conditions
Genitourinary Syndrome of Menopause
Interventions
DEVICE

Injectable form of multifractional intercalated cross-linked hyaluronic acid (Armonia®, Regenyal, Italy)

2 mL of Armonia was injected into the vaginal wall with a standardized injection technique called Cannulated Intravaginal Injection Technique®. In this technique, Armonia® was injected as drops at 40 different points on the entire vaginal wall using 8 different entry points

Trial Locations (1)

34844

Maltepe University Faculty of Medicine, Istanbul

All Listed Sponsors
lead

Maltepe University

OTHER

NCT05559996 - Assessment of the Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause | Biotech Hunter | Biotech Hunter